2015
DOI: 10.1073/pnas.1502960112
|View full text |Cite
|
Sign up to set email alerts
|

The Fe-S cluster-containing NEET proteins mitoNEET and NAF-1 as chemotherapeutic targets in breast cancer

Abstract: Identification of novel drug targets and chemotherapeutic agents is a high priority in the fight against cancer. Here, we report that MAD-28, a designed cluvenone (CLV) derivative, binds to and destabilizes two members of a unique class of mitochondrial and endoplasmic reticulum (ER) 2Fe-2S proteins, mitoNEET (mNT) and nutrient-deprivation autophagy factor-1 (NAF-1), recently implicated in cancer cell proliferation. Docking analysis of MAD-28 to mNT/NAF-1 revealed that in contrast to CLV, which formed a hydrog… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
65
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
3

Relationship

3
5

Authors

Journals

citations
Cited by 70 publications
(70 citation statements)
references
References 30 publications
5
65
0
Order By: Relevance
“…4 and 5). These findings support our previous report that NAF-1 could be one of the cellular targets of a mitocan that affects its cluster stability and causes an increase in mitochondrial iron and ROS accumulation (33). Taken together, our findings suggest that any drastic change in the lability of the NAF-1 cluster would impair its function in maintaining the levels of iron and ROS in mitochondria under control.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…4 and 5). These findings support our previous report that NAF-1 could be one of the cellular targets of a mitocan that affects its cluster stability and causes an increase in mitochondrial iron and ROS accumulation (33). Taken together, our findings suggest that any drastic change in the lability of the NAF-1 cluster would impair its function in maintaining the levels of iron and ROS in mitochondria under control.…”
Section: Discussionsupporting
confidence: 92%
“…The druggable binding site on NAF-1 was identified by a four-step computational scheme in our previous work (33). Based on this finding, the binding of PGZ to NAF-1 was studied by our in-house docking molecular tool iFitDock (details in SI Materials and Methods).…”
Section: Meta-analysis Of Transcriptomics Data From 21 Tn (Er- Pr-mentioning
confidence: 99%
“…One important target is the mitochondrion, which undergoes apoptosis under drug treatment (27). MAD28 has recently been shown to inhibit an iron-sulfur cluster binding protein, mitoNEET, on the outer membrane of mitochondria in breast cancer cells (29). MitoNEET is involved in cellular iron homeostasis and various mitochondrial functions (42).…”
Section: Resultsmentioning
confidence: 99%
“…Although the detailed mechanism of action of GBA, CLV, and related compounds has not yet been delineated, several studies indicate that they localize to mitochondria and exhibit their bioactivity by affecting mitochondrial structure and function (27,28). Along these lines, the hydroxylated CLVs MAD28 and MAD44 were recently found to bind to the mitoNEET family of iron-sulfur-containing proteins that are located at the outer mitochondrial membrane (29).…”
mentioning
confidence: 99%
“…Finally, small molecules targeting mNEET or miner1 have been characterized (22,23) and may be used to treat cancer, diabetes, or other pathological conditions. In this perspective, it is essential to understand fully the cellular functions of mNEET, miner1, and miner2 to determine the effects of such compounds on cellular physiology.…”
Section: Discussionmentioning
confidence: 99%